AzTrials
AzTrials

Scapular DyskinesisNCT07001228

Scapular Dyskinesis With Impingement Syndrome

A study testing SD rehabilitation and No SD rehabilitation in people with Scapular Dyskinesis and Impingement Syndrome, Shoulder, run by Chuncheon Sacred Heart Hospital at 1 site in South Korea.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this study is to diagnose scapular dyskinesis-which can appear as a cause or result of various shoulder disorders-through screening tests in patients with shoulder impingement syndrome, the most common shoulder condition. Read more about this study

Who is it for?
Ages 20 years and older
What is being tested?
SD rehabilitation and No SD rehabilitation
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
360 participants
Where
1 siteSouth Korea
Study dates
29 May 2025to 31 May 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult
  1. Inclusion Criteria Patients diagnosed with unilateral shoulder impingement syndrome in the outpatient clinic (based on clinical symptoms and MRI) from the IRB approval date until March 1, 2027 Individuals who provided written informed consent after receiving a thorough explanation of the study prior to any procedures Age 20 years or older
  2. Exclusion Criteria

Individuals who did not receive a subacromial steroid injection for shoulder impingement syndrome

Individuals with a history of surgical treatment or fracture in the affected shoulder

Individuals who refused to participate in the study

Individuals with neurological disorders affecting the ipsilateral upper extremity

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Jung-Taek Hwang, MD, PhD contact

+82332405197

drakehjt@hanmail.net

Su-Jung Seo, PhD contact

asasa4444@naver.com

South Korea1 site
  • Hallym University Chuncheon Sacred Heart Hospital

    Chuncheon, Gangwon-do, 24253

    Su-Jung Seo, PhD, +82332405197, asasa4444@naver.com

Other trials in South Korea

About this study

Official title: Diagnosis and Treatment of Scapular Dyskinesis Combined With Impingement Syndrome of Shoulder

The goal of this study is to diagnose scapular dyskinesis-which can appear as a cause or result of various shoulder disorders-through screening tests in patients with shoulder impingement syndrome, the most common shoulder condition. By identifying scapular dyskinesis, the study aims to maximize treatment outcomes through appropriate rehabilitative exercise therapy.

Being tested
SD rehabilitation, No SD rehabilitation
Medical subject headings
Shoulder Impingement Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SD rehabilitationBehavioural

    For shoulder impingement syndrome, the standard rehabilitation protocol involves administering a subacromial steroid injection at the initial outpatient visit, followed by stick exercises to restore joint mobility starting three weeks later. Four weeks after initiating the stick exercises, rotator cuff strengthening exercises using therabands are introduced and maintained for a duration of six weeks.

    For SD rehabilitation, shoulder external rotation, push up plus, and shoulder rolls were performed. In the experimental group, rehabilitation for scapular dyskinesis will begin at the second outpatient visit, which takes place three weeks after the subacromial steroid injection.

  • No SD rehabilitationBehavioural

    For shoulder impingement syndrome, the standard rehabilitation protocol involves administering a subacromial steroid injection at the initial outpatient visit, followed by stick exercises to restore joint mobility starting three weeks later. Four weeks after initiating the stick exercises, rotator cuff strengthening exercises using therabands are introduced and maintained for a duration of six weeks.

    In the sham group, rehabilitation for scapular dyskinesis will not begun at the second outpatient visit, which takes place three weeks after the subacromial steroid injection.

Study groups in NCT07001228
Study groupRoleWhat they receive
Impinge c SD treatmentExperimentalIn this experimental group, rehabilitation for scapular dyskinesis will begin at the second outpatient visit, which takes place three weeks after the subacromial steroid injection.
Receives: Behavioral: SD rehabilitation
Impinge s SD treatmentSham comparatorIn this sham group, rehabilitation for scapular dyskinesis will not be begun at the second outpatient visit, which takes place three weeks after the subacromial steroid injection.
Receives: Behavioral: No SD rehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. visual analog pain scale (VAS)

    0-10, 0: not satisfied, 10: very much satisfied

    Measured: Initial, 3, 7, 13 weeks

Secondary outcomes (2)
  1. American Shoulder and Elbow Surgeons' (ASES) score

    0-100

    Measured: Initial, 3, 7,13 weeks

  2. Constant score

    0-100

    Measured: Initial, 3, 7, 13 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jun 2025
  2. Study start29 May 2025 (estimated)
  3. Primary completion31 May 2027 (estimated)
  4. Study completion31 May 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Model description
This study involves patients who visited the outpatient clinic with unilateral shoulder pain persisting for more than three months and were diagnosed with unilateral shoulder impingement syndrome based on MRI findings. Only patients who provided informed consent were enrolled in the study. A total of 320 patients with unilateral shoulder impingement syndrome from Chuncheon Sacred Heart Hospital were included. The participants were randomly assigned into two groups of 160 patients each. Both groups underwent rehabilitation for shoulder impingement syndrome; however, the control group (Group 1) did not receive rehabilitation for scapular dyskinesis, while the experimental group (Group 2) did receive rehabilitation targeting scapular dyskinesis.
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
360 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07001228
Sponsor's protocol ID
2025-03-009-002
Status last verified
Jun 2025
First submitted
23 May 2025
Last updated
6 Jun 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: We can decide it after the termination of this study.

Publications

  • Park JY, Hwang JT, Oh KS, Kim SJ, Kim NR, Cha MJ. Revisit to scapular dyskinesis: three-dimensional wing computed tomography in prone position. J Shoulder Elbow Surg. 2014 Jun;23(6):821-8. doi: 10.1016/j.jse.2013.08.016. Epub 2013 Nov 23.

    PubMed 24280352
  • Park JY, Hwang JT, Kim KM, Makkar D, Moon SG, Han KJ. How to assess scapular dyskinesis precisely: 3-dimensional wing computer tomography--a new diagnostic modality. J Shoulder Elbow Surg. 2013 Aug;22(8):1084-91. doi: 10.1016/j.jse.2012.10.046. Epub 2013 Jan 24.

    PubMed 23352185
  • Kibler WB, McMullen J. Scapular dyskinesis and its relation to shoulder pain. J Am Acad Orthop Surg. 2003 Mar-Apr;11(2):142-51. doi: 10.5435/00124635-200303000-00008.

    PubMed 12670140
  • Kibler WB, Ludewig PM, McClure P, Uhl TL, Sciascia A. Scapular Summit 2009: introduction. July 16, 2009, Lexington, Kentucky. J Orthop Sports Phys Ther. 2009 Nov;39(11):A1-A13. doi: 10.2519/jospt.2009.0303.

    PubMed 19881011

Questions about this trial

What is this clinical trial studying?

A study testing SD rehabilitation and No SD rehabilitation in people with Scapular Dyskinesis and Impingement Syndrome, Shoulder, run by Chuncheon Sacred Heart Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 6 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jung-Taek Hwang, MD, PhD (+82332405197, drakehjt@hanmail.net), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

visual analog pain scale (VAS) (time frame: Initial, 3, 7, 13 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07001228, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in